Mifepristone and misoprostol are different medicines. Mifepristone blocks progesterone, while misoprostol causes the uterus to contract. In evidence-based medication abortion care they may be used together, or misoprostol may be used in other clinically appropriate circumstances.
Cytotec is a brand name for misoprostol; it is not a combined mifepristone-and-misoprostol product. Both medicines have contraindications, side effects and prescription requirements. A licensed clinician should determine whether either medicine is appropriate.
Why the Name on the Pack Is Not Enough
Brand names can vary between countries and suppliers. A name such as Cytotec or Mifegest does not, by itself, confirm the generic ingredients, strength, manufacturer, expiry date or authenticity of a pack. Those details should be checked against the sealed packaging, prescription and information supplied by a licensed professional. Price, delivery speed or an online photograph cannot establish that a medicine is genuine or suitable for an individual pregnancy.
What Safe, Lawful Care Should Clarify
A qualified clinician should explain the generic name of each medicine, why it is being considered, expected effects, important contraindications and where urgent help is available. Assessment may include pregnancy duration and location, current symptoms, medical history, allergies and other medicines. The WHO Clinical Practice Handbook describes quality care as including accurate information, consent, confidentiality, pain management and appropriate post-abortion care.
Clinical guidance does not replace UAE law. Cabinet Resolution No. 44 of 2024 regulates permitted circumstances, authorised facilities and procedural conditions. Individual eligibility should be confirmed by an authorised UAE health facility or a qualified local legal professional.
Sources: World Health Organization clinical guidance and the official UAE legislation portal. This is general education, not a diagnosis, prescription or guarantee of outcome.